NASDAQ
Medexus Pharmaceuticals Inc. (MEDXF) has a fcf yield of 49.71% as of Friday, May 29, 2026. This represents a 388.20% increase compared to its 12-month average of 10.18%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.